Stock Analysis

Discover Three Undiscovered Gems in Hong Kong This August 2024

SEHK:1666
Source: Shutterstock

As global markets experience volatility and economic indicators signal mixed sentiments, the Hong Kong market has shown resilience, particularly in its small-cap sector. With the Russell 2000 Index pulling back sharply, investors are increasingly looking for hidden opportunities that may offer growth potential amidst broader market fluctuations. In this context, identifying stocks with strong fundamentals and unique value propositions becomes crucial. Here are three undiscovered gems in Hong Kong that could be worth exploring this August 2024.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
E-Commodities Holdings23.22%6.87%31.81%★★★★★★
S.A.S. Dragon Holdings37.35%4.13%12.06%★★★★★★
COSCO SHIPPING International (Hong Kong)NA-12.97%12.59%★★★★★★
PW Medtech GroupNA17.93%-2.70%★★★★★★
Tianyun International Holdings10.09%-5.59%-9.92%★★★★★★
Xin Point Holdings2.03%9.80%15.04%★★★★★☆
Hung Hing Printing Group3.97%-2.51%33.57%★★★★★☆
Changjiu Holdings14.09%12.87%-4.74%★★★★★☆
Time Interconnect Technology212.50%27.21%15.01%★★★★☆☆
Pizu Group Holdings48.34%-4.53%-19.78%★★★★☆☆

Click here to see the full list of 173 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

Underneath we present a selection of stocks filtered out by our screen.

Tong Ren Tang Technologies (SEHK:1666)

Simply Wall St Value Rating: ★★★★★★

Overview: Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally, with a market cap of HK$6.67 billion.

Operations: Tong Ren Tang Technologies generates revenue primarily from its own operations (CN¥4.07 billion) and Tong Ren Tang Chinese Medicine (CN¥1.38 billion).

Tong Ren Tang Technologies, a smaller player in Hong Kong's market, has shown promising financial health. The company reported earnings growth of 1.3% over the past year, outpacing the pharmaceutical industry’s 0.1%. It also boasts a net profit margin of 12%, reflecting efficient operations. Recent events include appointing Ernst & Young as auditors and announcing a final dividend of RMB 0.18 per share for FY2023, payable on August 9, 2024.

SEHK:1666 Debt to Equity as at Aug 2024
SEHK:1666 Debt to Equity as at Aug 2024

Guoquan Food (Shanghai) (SEHK:2517)

Simply Wall St Value Rating: ★★★★★☆

Overview: Guoquan Food (Shanghai) Co., Ltd. operates as a home meal products company in China with a market cap of HK$8.93 billion.

Operations: Guoquan Food (Shanghai) Co., Ltd. generates revenue primarily from retail sales through grocery stores, amounting to CN¥6.09 billion.

Guoquan Food (Shanghai) has shown promising growth, with earnings increasing by 4.2% over the past year, outpacing the Consumer Retailing industry’s 1.6%. The company’s levered free cash flow turned positive in 2022 at RMB 167 million and surged to RMB 543 million in 2023. Recent board changes include Mr. Wang Hui taking on dual roles as CFO and joint company secretary since February 2024, bringing extensive financial expertise to the table.

SEHK:2517 Earnings and Revenue Growth as at Aug 2024
SEHK:2517 Earnings and Revenue Growth as at Aug 2024

Sinopec Kantons Holdings (SEHK:934)

Simply Wall St Value Rating: ★★★★★★

Overview: Sinopec Kantons Holdings Limited, an investment holding company, provides crude oil jetty services and has a market cap of HK$10.94 billion.

Operations: Sinopec Kantons Holdings generates revenue primarily from crude oil jetty and storage services, amounting to HK$609.87 million. The company's net profit margin is a key financial metric to consider.

Sinopec Kantons Holdings experienced a remarkable earnings growth of 198.6% over the past year, outpacing the Oil and Gas industry's -6.8%. The company is debt-free, a significant improvement from its 31.4% debt-to-equity ratio five years ago. Trading at 78.3% below its estimated fair value, it also boasts high-quality earnings and positive free cash flow. Recent leadership changes saw Mr. Zhong Fuliang appointed as Chairman, bringing extensive industry experience to the role.

SEHK:934 Debt to Equity as at Aug 2024
SEHK:934 Debt to Equity as at Aug 2024

Make It Happen

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Tong Ren Tang Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com